These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20962354)

  • 1. Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.
    Kernt M; Neubauer AS; Liegl RG; Hirneiss C; Alge CS; Wolf A; Ulbig MW; Kampik A
    Br J Ophthalmol; 2010 Nov; 94(11):1533-9. PubMed ID: 20962354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
    Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
    Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor.
    Kernt M; Liegl RG; Rueping J; Neubauer AS; Haritoglou C; Lackerbauer CA; Eibl KH; Ulbig MW; Kampik A
    Growth Factors; 2010 Jun; 28(3):211-20. PubMed ID: 20166888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium].
    Kernt M; Thiele S; Hirneiss C; Neubauer AS; Lackerbauer CA; Wolf A; Eibl KH; Haritoglou C; Ulbig MW; Kampik A
    Ophthalmologe; 2011 May; 108(5):445-51. PubMed ID: 21253747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.
    Kernt M; Thiele S; Liegl RG; Kernt B; Eibl K; Haritoglou C; Ulbig MW; Kampik A
    Growth Factors; 2012 Feb; 30(1):49-61. PubMed ID: 22168366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression.
    Kernt M; Neubauer AS; Liegl R; Eibl KH; Alge CS; Lackerbauer CA; Ulbig MW; Kampik A
    J Cataract Refract Surg; 2009 Feb; 35(2):354-62. PubMed ID: 19185255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic and cytotoxic effects of minocycline on human retinal pigment epithelial cells.
    Hollborn M; Wiedemann P; Bringmann A; Kohen L
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2721-9. PubMed ID: 20019360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX-LDL up-regulates the vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in human retinal pigment epithelial cells.
    Yin L; Wu X; Gong Y; Shi Y; Qiu Y; Zhang H; Liu X; Gu Q
    Curr Eye Res; 2011 Apr; 36(4):379-85. PubMed ID: 21348596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells.
    Kociok N; Heppekausen H; Schraermeyer U; Esser P; Thumann G; Grisanti S; Heimann K
    Exp Eye Res; 1998 Aug; 67(2):237-50. PubMed ID: 9733590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors.
    Hollborn M; Petto C; Steffen A; Trettner S; Bendig A; Wiedemann P; Bringmann A; Kohen L
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4452-9. PubMed ID: 19369239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
    Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gene expression of angiogenic factors induced by calcium-mediated dissociation of retinal pigment epithelial cells.
    Wang XF; Cui JZ; Prasad SS; Matsubara JA
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1508-15. PubMed ID: 15790923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro.
    Puddu A; Sanguineti R; Traverso CE; Viviani GL; Nicolò M
    Eur J Ophthalmol; 2016 Aug; 26(5):425-30. PubMed ID: 27079208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells.
    Lombardi G; Calistri A; Curtarello M; Giudice GL; Piermarocchi S; Prosdocimo G; Palù G; Parolin C
    Br J Ophthalmol; 2009 Feb; 93(2):244-8. PubMed ID: 19174401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
    Jane EP; Premkumar DR; Pollack IF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothermia reduces secretion of vascular endothelial growth factor by cultured retinal pigment epithelial cells.
    Coassin M; Duncan KG; Bailey KR; Singh A; Schwartz DM
    Br J Ophthalmol; 2010 Dec; 94(12):1678-83. PubMed ID: 20805126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.